Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Assets Average (2020 - 2025)

Historic Assets Average for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to $1.8 billion.

  • Avidity Biosciences' Assets Average rose 1723.24% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 1723.24%. This contributed to the annual value of $1.1 billion for FY2024, which is 7299.41% up from last year.
  • As of Q3 2025, Avidity Biosciences' Assets Average stood at $1.8 billion, which was up 1723.24% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Avidity Biosciences' Assets Average ranged from a high of $1.8 billion in Q3 2025 and a low of $302.6 million during Q2 2021
  • For the 5-year period, Avidity Biosciences' Assets Average averaged around $808.5 million, with its median value being $600.9 million (2023).
  • In the last 5 years, Avidity Biosciences' Assets Average surged by 213.15% in 2021 and then surged by 16667.37% in 2024.
  • Avidity Biosciences' Assets Average (Quarter) stood at $426.7 million in 2021, then increased by 25.29% to $534.7 million in 2022, then rose by 12.38% to $600.9 million in 2023, then surged by 166.67% to $1.6 billion in 2024, then increased by 9.31% to $1.8 billion in 2025.
  • Its Assets Average stands at $1.8 billion for Q3 2025, versus $1.4 billion for Q2 2025 and $1.5 billion for Q1 2025.